Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
38,354,600
-
Share change
-
-1,865,396
-
Total reported value
-
$4,783,347
-
Price per share
-
$0.12
-
Number of holders
-
78
-
Value change
-
-$222,623
-
Number of buys
-
34
-
Number of sells
-
26
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q1 2023
As of 31 Mar 2023,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,354,600 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, MAI Capital Management, Bank of New York Mellon Corp, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and TWO SIGMA INVESTMENTS, LP.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.